
Rezolute, Inc.
RZLTHealthcare|Biotechnology|US
$3.88
+0.24 (+6.59%)
DCF Value
$0.05
Tangible Book / Share
$0.82
Cash / Share
$0.86
Ownership Breakdown
62.8%
Float
96.7M
Shares Outstanding
60.8M
Float Shares
Major Holders (28)
Combined: 156.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | IA, PN | 9.90% | 9,180,000 | Dec 18, 2025 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 9,180,000 | Dec 18, 2025 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 15,302,186 | Dec 18, 2025 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 9,180,000 | Dec 18, 2025 | 13D/G |
| James Silverman | Individual | 6.58% | 6,300,000 | May 11, 2026 | 13D/G |
| Opaleye Management Inc. | IA, CO | 6.58% | 6,300,000 | May 11, 2026 | 13D/G |
| Opaleye, L.P. | Partnership | 6.44% | 6,165,000 | May 11, 2026 | 13D/G |
| Kevin Pyun | HC, IN | 5.90% | 5,721,834 | Aug 12, 2026 | 13D/G |
| Dellora Investments LP | IA, HC | 5.90% | 5,721,834 | Aug 12, 2026 | 13D/G |
| Jennison Associates LLC | Investment adviser | 5.50% | 5,332,068 | Oct 28, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.40% | 4,881,509 | Oct 17, 2025 | 13D/G |
| Dellora Investments Master Fund LP | Partnership | 5.10% | 4,873,868 | Aug 12, 2026 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 4.93% | 2,857,982 | Feb 14, 2025 | 13D/G |
| Daniel Mack | Holding company | 4.93% | 2,857,982 | Feb 14, 2025 | 13D/G |
| Wilmot B. Harkey | Holding company | 4.93% | 2,857,982 | Feb 14, 2025 | 13D/G |
| Phillip Gross | HC, IN | 4.91% | 2,842,163 | Nov 12, 2024 | 13D/G |
| Adage Capital Management, L.P. | IA, PN | 4.91% | 2,842,163 | Nov 12, 2024 | 13D/G |
| Robert Atchinson | HC, IN | 4.91% | 2,842,163 | Nov 12, 2024 | 13D/G |
| Balyasny Asset Management L.P. | IA, PN | 4.84% | 4,662,039 | Aug 14, 2026 | 13D/G |
| Dmitry Balyasny | HC, IN | 4.84% | 4,662,039 | Aug 14, 2026 | 13D/G |
| Dames GP LLC | HC, OO | 4.84% | 4,662,039 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management Holdings LP | HC, PN | 4.84% | 4,662,039 | Aug 14, 2026 | 13D/G |
| Bam GP LLC | HC, OO | 4.84% | 4,662,039 | Aug 14, 2026 | 13D/G |
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 4.80% | 2,797,704 | Nov 14, 2024 | 13D/G |
| Vivo Opportunity, LLC | Other | 4.80% | 2,797,704 | Nov 14, 2024 | 13D/G |
| FMR LLC | Holding company | 2.50% | 2,305,568 | Jan 8, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 2.50% | 2,305,568 | Jan 8, 2026 | 13D/G |
| Bank of America Corp /De/ | Holding company | 1.20% | 1,176,889 | Aug 12, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,253,750 acquired · 82,890 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO | Oct 21, 2026 | GIFT | 16,000 | — | — | Form 4 |
| Evans Daron | CFO | Oct 21, 2026 | GIFT | 4,000 | — | — | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Sep 2, 2026 | TAX W/H | 2,267 | $4.50 | $10.2K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jul 2, 2026 | TAX W/H | 3,062 | $4.99 | $15.3K | Form 4 |
| Elam Nevan C | director, officer: CEO | Jul 2, 2026 | TAX W/H | 8,004 | $4.99 | $39.9K | Form 4 |
| Evans Daron | CFO | Jul 2, 2026 | TAX W/H | 3,062 | $4.99 | $15.3K | Form 4 |
| Evans Daron | CFO | Mar 30, 2026 | BUY | 10,000 | $2.85 | $28.5K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Mar 2, 2026 | TAX W/H | 11,439 | $2.99 | $34.2K | Form 4 |
| Evans Daron | CFO | Mar 2, 2026 | TAX W/H | 11,438 | $2.99 | $34.2K | Form 4 |
| Elam Nevan C | director, officer: CEO | Mar 2, 2026 | TAX W/H | 27,618 | $2.99 | $82.6K | Form 4 |
| Hogenhuis Wladimir | director | Dec 16, 2025 | BUY | 5,650 | $1.69 | $9.5K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Dec 16, 2025 | BUY | 28,000 | $1.70 | $47.6K | Form 4 |
| Evans Daron | CFO | Dec 15, 2025 | BUY | 40,000 | $1.77 | $70.6K | Form 4 |
| Evans Daron | CFO | Dec 15, 2025 | BUY | 2,500 | $1.78 | $4.5K | Form 4 |
| Evans Daron | CFO | Dec 15, 2025 | BUY | 2,500 | $1.79 | $4.5K | Form 4 |
| Elam Nevan C | director, officer: CEO | Dec 15, 2025 | BUY | 32,000 | $1.59 | $50.9K | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Dec 15, 2025 | BUY | 100 | $1.60 | $160.00 | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Dec 15, 2025 | BUY | 12,000 | $1.62 | $19.4K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Nov 19, 2025 | AWARD | 123,000 | — | — | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Nov 19, 2025 | OTHER | 72,000 | $10.16 | $731.5K | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Nov 19, 2025 | AWARD | 32,000 | — | — | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Nov 19, 2025 | AWARD | 19,000 | $10.16 | $193.0K | Form 4 |
| Elam Nevan C | director, officer: CEO | Nov 19, 2025 | AWARD | 317,000 | — | — | Form 4 |
| Elam Nevan C | director, officer: CEO | Nov 19, 2025 | AWARD | 186,000 | $10.16 | $1.9M | Form 4 |
| Evans Daron | CFO | Nov 19, 2025 | AWARD | 107,000 | — | — | Form 4 |
| Evans Daron | CFO | Nov 19, 2025 | AWARD | 63,000 | $10.16 | $640.1K | Form 4 |
| KREHER NERISSA | director | Nov 19, 2025 | AWARD | 21,000 | — | — | Form 4 |
| KREHER NERISSA | director | Nov 19, 2025 | AWARD | 12,000 | $10.16 | $121.9K | Form 4 |
| Hogenhuis Wladimir | director | Nov 19, 2025 | AWARD | 21,000 | — | — | Form 4 |
| Hogenhuis Wladimir | director | Nov 19, 2025 | AWARD | 12,000 | $10.16 | $121.9K | Form 4 |
| Harris Erik | director | Nov 19, 2025 | AWARD | 21,000 | — | — | Form 4 |
| Harris Erik | director | Nov 19, 2025 | AWARD | 12,000 | $10.16 | $121.9K | Form 4 |
| Kim Young-Jin | director | Nov 19, 2025 | AWARD | 21,000 | — | — | Form 4 |
| Kim Young-Jin | director | Nov 19, 2025 | AWARD | 12,000 | $10.16 | $121.9K | Form 4 |
| FAUCHET PHILIPPE | director | Nov 19, 2025 | AWARD | 21,000 | — | — | Form 4 |
| FAUCHET PHILIPPE | director | Nov 19, 2025 | AWARD | 12,000 | $10.16 | $121.9K | Form 4 |
| Labrucherie Gil M | director | Nov 19, 2025 | AWARD | 21,000 | — | — | Form 4 |
| Labrucherie Gil M | director | Nov 19, 2025 | AWARD | 12,000 | $10.16 | $121.9K | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Aug 18, 2025 | AWARD | 275,000 | $6.55 | $1.8M | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Aug 18, 2025 | AWARD | 25,000 | — | — | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Aug 18, 2025 | OTHER | 0 | — | — | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Aug 18, 2025 | OTHER | 0 | — | — | Form 4 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Aug 18, 2025 | OTHER | 0 | — | — | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 25, 2025 | BUY | 2,500 | $4.38 | $10.9K | Form 4 |
| Evans Daron | CFO | Jun 24, 2025 | BUY | 5,000 | $4.05 | $20.3K | Form 4 |
| Kim Young-Jin | director | Jun 13, 2025 | BUY | 1,230,769 | $3.25 | $4.0M | Form 4 |
| KREHER NERISSA | director | Jun 13, 2025 | BUY | 3,076 | $3.25 | $10.0K | Form 4 |
| KREHER NERISSA | director | Jun 10, 2025 | AWARD | 9,000 | — | — | Form 4 |
| KREHER NERISSA | director | Jun 10, 2025 | AWARD | 5,000 | $4.39 | $21.9K | Form 4 |
| Labrucherie Gil M | director | Jun 10, 2025 | AWARD | 9,000 | — | — | Form 4 |
| Labrucherie Gil M | director | Jun 10, 2025 | AWARD | 5,000 | $4.39 | $21.9K | Form 4 |
| Hogenhuis Wladimir | director | Jun 10, 2025 | AWARD | 9,000 | — | — | Form 4 |
| Hogenhuis Wladimir | director | Jun 10, 2025 | AWARD | 5,000 | $4.39 | $21.9K | Form 4 |
| Kim Young-Jin | director | Jun 10, 2025 | AWARD | 9,000 | — | — | Form 4 |
| Kim Young-Jin | director | Jun 10, 2025 | AWARD | 5,000 | $4.39 | $21.9K | Form 4 |
| Evans Daron | CFO | Jun 10, 2025 | AWARD | 26,000 | — | — | Form 4 |
| Evans Daron | CFO | Jun 10, 2025 | AWARD | 15,000 | $4.39 | $65.8K | Form 4 |
| FAUCHET PHILIPPE | director | Jun 10, 2025 | AWARD | 9,000 | — | — | Form 4 |
| FAUCHET PHILIPPE | director | Jun 10, 2025 | AWARD | 5,000 | $4.39 | $21.9K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 10, 2025 | AWARD | 26,000 | — | — | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 10, 2025 | AWARD | 15,000 | $4.39 | $65.8K | Form 4 |
| Elam Nevan C | director, officer: CEO | Jun 10, 2025 | AWARD | 68,000 | — | — | Form 4 |
| Elam Nevan C | director, officer: CEO | Jun 10, 2025 | AWARD | 40,000 | $4.39 | $175.6K | Form 4 |
| Hogenhuis Wladimir | director | Mar 31, 2025 | BUY | 6,758 | $2.92 | $19.7K | Form 4 |
| Elam Nevan C | director, officer: CEO | Mar 27, 2025 | BUY | 12,302 | $2.85 | $35.0K | Form 4 |
| Evans Daron | CFO | Mar 26, 2025 | BUY | 10,000 | $2.89 | $28.9K | Form 4 |
| Evans Daron | CFO | Mar 26, 2025 | BUY | 10,000 | $2.88 | $28.8K | Form 4 |
| Harris Erik | director | Mar 25, 2025 | AWARD | 60,000 | $2.89 | $173.4K | Form 4 |
| Harris Erik | Mar 25, 2025 | OTHER | 0 | — | — | Form 4 | |
| Hogenhuis Wladimir | director | Feb 18, 2025 | BUY | 10,000 | $4.70 | $47.0K | Form 4 |
| Hogenhuis Wladimir | director | Feb 16, 2025 | AWARD | 25,500 | — | — | Form 4 |
| Hogenhuis Wladimir | director | Feb 16, 2025 | AWARD | 15,000 | $4.61 | $69.2K | Form 4 |
| Labrucherie Gil M | director | Feb 16, 2025 | AWARD | 25,500 | — | — | Form 4 |
| Labrucherie Gil M | director | Feb 16, 2025 | AWARD | 15,000 | $4.61 | $69.2K | Form 4 |
| Evans Daron | CFO | Feb 16, 2025 | AWARD | 77,000 | — | — | Form 4 |
| Evans Daron | CFO | Feb 16, 2025 | AWARD | 45,000 | $4.61 | $207.4K | Form 4 |
| KREHER NERISSA | director | Feb 16, 2025 | AWARD | 25,500 | — | — | Form 4 |
| KREHER NERISSA | director | Feb 16, 2025 | AWARD | 15,000 | $4.61 | $69.2K | Form 4 |
| Kim Young-Jin | director | Jun 25, 2024 | BUY | 1,250,000 | $4.00 | $5.0M | Form 4 |
| Kim Young-Jin | director | Feb 16, 2025 | AWARD | 25,500 | — | — | Form 4 |
| Kim Young-Jin | director | Feb 16, 2025 | AWARD | 15,000 | $4.61 | $69.2K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Feb 16, 2025 | AWARD | 77,000 | — | — | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Feb 16, 2025 | AWARD | 45,000 | $4.61 | $207.4K | Form 4 |
| Elam Nevan C | director, officer: CEO | Feb 16, 2025 | AWARD | 204,000 | — | — | Form 4 |
| Elam Nevan C | director, officer: CEO | Feb 16, 2025 | AWARD | 120,000 | $4.61 | $553.2K | Form 4 |
| FAUCHET PHILIPPE | director | Feb 16, 2025 | AWARD | 25,500 | — | — | Form 4 |
| FAUCHET PHILIPPE | director | Feb 16, 2025 | AWARD | 15,000 | $4.61 | $69.2K | Form 4 |
| Evans Daron | CFO | Dec 18, 2024 | BUY | 10,000 | $4.29 | $42.9K | Form 4 |
| Evans Daron | CFO | Dec 12, 2024 | BUY | 9,000 | $4.60 | $41.4K | Form 4 |
| Evans Daron | CFO | Dec 9, 2025 | BUY | 10,549 | $5.04 | $53.2K | Form 4 |
| Hogenhuis Wladimir | director | Sep 24, 2024 | BUY | 4,259 | $4.70 | $20.0K | Form 4 |
| Evans Daron | CFO | Sep 23, 2024 | AWARD | 100,000 | $4.79 | $479.0K | Form 4 |
| Hogenhuis Wladimir | director | Jun 25, 2024 | BUY | 4,815 | $4.15 | $20.0K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 14, 2024 | BUY | 300 | $3.96 | $1.2K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 14, 2024 | BUY | 4,000 | $3.91 | $15.6K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 14, 2024 | BUY | 3,000 | $3.91 | $11.7K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | Jun 14, 2024 | BUY | 300 | $3.97 | $1.2K | Form 4 |
| Evans Daron | CFO | Jun 14, 2024 | BUY | 40,000 | $4.04 | $161.6K | Form 4 |
| Evans Daron | CFO | May 29, 2024 | BUY | 451 | $3.50 | $1.6K | Form 4 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer | May 23, 2024 | BUY | 6,000 | $2.68 | $16.1K | Form 4 |